Prone and supine position and airway pressure in patients with COVID-19 associated and non-COVID-19 associated ARDS
Not Applicable
- Conditions
- GENVERSAGE
- Registration Number
- DRKS00027258
- Lead Sponsor
- Anästhesiologische Universitätsklinik Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
prone positioning-therapy in patients in COVID-19 associated or non-COVID-19 associated ARDS
Exclusion Criteria
Age <18 years, pregnancy, known higher-grade valvular ventricular disease (third-grade stenosis or insufficiency), heart failure > NYHA 2, acute right heart failure, therapy with inhaled NO, ECMO, contraindications for EIT measurements (active implants, eg. pacemaker, cardioverter), BMI = 35 kg*m-2, traumatic brain injury, or intracerebral hemorrhage.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Index of oxygenation (paO2/FiO2)
- Secondary Outcome Measures
Name Time Method Homogenity of regional ventilation
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does prone positioning modulate cytokine release and alveolar mechanics in ARDS (NCT DRKS00027258)?
What is the comparative effectiveness of prone vs. supine positioning in ARDS with hypoxemic respiratory failure (NCT DRKS00027258)?
Which biomarkers correlate with improved oxygenation in prone-positioned ARDS patients (NCT DRKS00027258)?
What are the safety profiles of prolonged prone positioning in ARDS and pressure ulcer prevention strategies (NCT DRKS00027258)?
How does prone positioning interact with mechanical ventilation parameters in ARDS management (NCT DRKS00027258)?